Date: 01/01/2026 Location: VIC
Introduction to Medical Cannabis: With Real Patient Studies provides healthcare professionals with a structured overview of the foundations, evidence, and clinical application of medical cannabis. The presentation begins with an introduction to the endocannabinoid system (ECS), exploring its receptors, endogenous and plant-derived cannabinoids, and their physiological roles in maintaining homeostasis. Attendees are guided through the properties of key cannabinoids (CBD and THC), the concept of the entourage effect, available formulations, and scheduling under Australian regulations.The session examines current clinical evidence for medical cannabis in chronic non-cancer pain, anxiety, and sleep disturbance, highlighting both therapeutic potential and limitations in the literature. Safety considerations—including contraindications, side effects, drug interactions, and driving regulations—are discussed alongside prescribing pathways through the TGA’s Special Access Scheme and Authorised Prescriber models.Practical insights are reinforced through patient stories and lived experiences, including contributions from elite athletes managing chronic pain. The event concludes with a panel discussion and Qandamp;A, equipping participants with evidence-informed perspectives and practical knowledge to support safe, effective, and patient-centred prescribing.